Top Abstract Purchase Related
Home
>
Node
>
Subnode

Alterations of ABH antigens in leukemic patients

Uchikawa, M.

Nihon Rinsho. Japanese Journal of Clinical Medicine 55(9): 2369-2373

1997

ISSN/ISBN: 0047-1852
PMID: 9301302
Document Number: 469492
Recognition and resolution of ABO grouping discrepancies are essential skills in pre-transfusion testing. Discrepancies in ABO grouping can be characterized by inappropriate results in either cell or serum grouping. These unexpected reactions come in two categories: reduced reactivity or extra reactivity detected in initial tests. Weak or missing expression of A or B antigens have been reported in some patients with leukemia, resulting in weak or mix-field agglutination with routine typing reagents. We will discuss the relationship between ABH blood group antigenic status and an acquired disease: anomolous phenotypes observed in hemopoietic disorders. OR.

Document emailed within 1 workday
Secure & encrypted payments

Marinov, J.; Koubek, K.; Starý, J. 1993: Expression of CDw12 and CD17 cell surface antigens on leukemic cells from patients with blood malignancies Folia Biologica 39(3): 124-128
Wahren, B.; Gahrton, G.; Hammarström, S. 1980: Nonspecific cross-reacting antigen in normal and leukemic myeloid cells and serum of leukemic patients Cancer Research 40(6): 2039-2044
Radzikowski, C. 1978: Studies on cell surface antigens of mouse leukemic and normal lymphocytes. I. Categories of cell surface antigens on mouse leukemia and their serological identification Archivum Immunologiae et Therapiae Experimentalis 26(1-6): 89-93
Viza, D.; Davies, D.A.; Todd, R.; Bernard-Degani, O.; Bernard, C.; Harris, R. 1970: Determination, isolation and partial purification of leukemic antigens in humans La Presse Medicale 78(51): 2259-2264
Baker, M.A.; Falk, J.A.; Taub, R.N. 1977: Alloantisera to human leukemic blast cells: detection of leukemia-associated antigens (LAA) Progress in Clinical and Biological Research 16: 103-107
Balch, C.M.; Dougherty, P.A.; Vogler, L.B.; Ades, E.W.; Ferrone, S. 1978: A new B cell differentiation antigen (BDA) on normal and leukemic human B lymphocytes that is distinct from known DR (Ia-like) antigens Journal of Immunology 121(6): 2322-2328
Seon, B.K.; Yoshizaki, K.; Pressman, D. 1979: Detection and characterization of human leukemia-associated antigens on leukemic cell lines and thymocytes. II. Isolation of human thymus-leukemia-associated antigens from the cell surface and partial characterization Journal of Immunology 122(5): 1951-1959
Tien, H.F.; Hsiao, C.H.; Tang, J.L.; Tsay, W.; Hu, C.H.; Kuo, Y.Y.; Wang, C.H.; Chen, Y.C.; Shen, M.C.; Lin, D.T.; Lin, K.H.; Lin, K.S. 2000: Characterization of acute myeloid leukemia with MLL rearrangements--no increase in the incidence of coexpression of lymphoid-associated antigens on leukemic blasts Leukemia 14(6): 1025-1030
Isikawa, T.; Fukuda, Y.; Yahata, H.; Dohi, K. 1991: Alterations of the expression of HLA class II antigens on T lymphocytes and monocytes in MLR: preliminary report Nihon Geka Gakkai Zasshi 92(11): 1663
Polo, R.; José Galindo, M.; Martínez, E.; Alvarez, J.; Arévalo, Jé.Manuel.; Asensi, Víctor.; Cánoves, D.; Cáncer, E.; Collazos, J.; Estrada, V.; Gómez-Candela, C.; Johnston, S.; Locutura, J.; López-Aldeguer, Jé.; Lozano, F.; Miralles, C.; Muñoz-Sanz, Aín.; Ortega, E.; Pascua, J.; Pedrol, E.; Pulido, F.; San Martín, M.; Sanz, Jús.; Viciana, P.; Chamorro, L. 2006: Recommendations of the Study Group for Metabolic Alterations/Secretariat for the National AIDS Plan (GEAM/SPNS) on the management of metabolic and morphologic alterations in patients with HIV infection Enfermedades Infecciosas y Microbiologia Clinica 24(2): 96-117
Pimtanothai, N.; Kangwanshiratada, O.; Charoenwongse, P. 2003: Serological analysis of human leukocyte antigens-A and -B antigens in Thai patients with nasopharyngeal carcinoma Journal of the Medical Association of Thailand 86(Suppl): S237-S241
Wells, S.A.; Burdick, J.F.; Joseph, W.L.; Christiansen, C.L.; Wolfe, W.G.; Adkins, P.C. 1973: Delayed cutaneous hypersensitivity reactions to tumor cell antigens and to nonspecific antigens. Prognostic significance in patients with lung cancer Journal of Thoracic and Cardiovascular Surgery 66(4): 557-562
Lordon, R.E.; Wilson, R.L.; Shield, C.F.; Ferrone, S. 1981: Humoral immunity in renal transplantation Detection of cytotoxic antibodies to lymphocyte antigens other than HLA-A,B,C and Ia-like antigens in patients with vascular graft rejection Transplantation 32(4): 286-290
Takenaka, T.; Kimura, K.; Konda, C.; Sakano, T.; Shimoyama, M.; Kitahara, T.; Minato, K. 1983: Clinical studies of leukemic non-Hodgkin's lymphoma. I. Leukemic conversion factors Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 46(6): 1245-1255
Shibuya, T.; Okamura, S.; Niho, Y. 1987: Analysis of leukemic blast growth factor (LBGF) and autocrine secretion of CSF by leukemic blasts Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 50(8): 1578-1585
McKernan, L.N.; Largen, M.T. 1984: Thymocyte differentiation activity from the cloned monocyte/macrophage cell line RAW 264.7. Alterations in the expression of immature thymocyte surface antigens Journal of Immunology 133(3): 1362-1370
Greiner, J.; Döhner, H.; Schmitt, M. 2006: Cancer vaccines for patients with acute myeloid leukemia--definition of leukemia-associated antigens and current clinical protocols targeting these antigens Haematologica 91(12): 1653-1661
Fellous, M.; Erickson, R.P.; Gachelin, G.; Dubois, P.; Jacob, F. 1976: The time of appearance of Ia antigens during spermatogenesis in the mouse. Relationship between Ia antigens and H-2, beta 2 microglobulin and F9 antigens Folia Biologica 22(6): 381-383
Schäden, J. 1975: Experiences with isolation of leukemic patients Schweizerische Medizinische Wochenschrift 105(51): 1792-1794
Gurda, M.; Turowska, B. 1970: Distribution of the ABO and Rh-D systems in leukemic patients Folia Haematologica 94(4): 303-308